Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 553 shares at $612.67 ($339K) on 2020-06-29, disclosed to the SEC on 2020-06-30.
Open-market sale of $339k REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $609.46 | 39 | $24K | 7.0% |
| 2 | $610.73 | 58 | $35K | 10.5% |
| 3 | $611.44 | 50 | $31K | 9.0% |
| 4 | $612.67 | 153 | $94K | 27.7% |
| 5 | $612.67 | 153 | $94K | 27.7% |
| 6 | $614.64 | 69 |
| $42K |
| 12.5% |
| 7 | $616.67 | 31 | $19K | 5.6% |
| Total | $612.60 avg | 553 | $339K | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |